相关实验视频
Updated: Aug 13, 2026

11:40
Quantitative Autonomic Testing
Published on: July 19, 2011
56.7K
复习自主反应延迟:健康人群中可重复性的评估
Annie S Jose1, Shival Srivastav1, Bharati Mehta1
1Department of Physiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Advanced biomedical research
|October 16, 2024
概括
自主响应延迟 (ARL) 在健康成年人中显示了中等到良好的测试重复性. 这种新的参数,测量心率对静止反应的时间滞后,显示了诊断自主神经病变的潜力.
科学领域:
- 自主神经系统生理学 自主神经系统生理学
- 心血管监管 监管心血管系统
- 神经学 神经学
背景情况:
- 自主功能评估对于评估自主神经系统至关重要.
- 自主响应延迟 (ARL) 是一个反映神经通路完整性的新参数.
- 以前的研究没有评估ARL的测试-重复测试可重复性.
研究的目的:
- 评估自主响应延迟 (ARL) 的测试-重复测试可重复性.
- 评估ARL作为自主神经病变的潜在诊断指数.
主要方法:
- 在一个月内招募了31名健康成年人进行重复的姿势挑战测试.
- 从心电图数据计算出心动脉迟缓 (TL) 和心迟缓 (BL) 的时间.
- 使用类内相关系数 (ICC) 和变化系数 (CoV) 评估可重复性.
主要成果:
- 对TL (ICC=0.69) 和BL (ICC=0.77) 均观察到中等到良好的测试重复性.
- 对TL和BL的变化系数分别为14.8%和12.4%.
- 按性别对子组的分析显示,在男性和女性中均有一致的重复性.
结论:
- ARL表现出中等到良好的测试重复测试可重复性.
- ARL显示出作为评估自主神经通路完整性的一致和可重复指数的潜力.
- ARL可能有助于诊断自主神经病变.
相关概念视频
Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

